Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial.
<h4>Objective</h4>This randomized controlled clinical trial aimed to evaluate the effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) in the treatment of dentin hypersensitivity (DH), and the impact of this on the health-relate...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0225501 |
id |
doaj-20870c2a9c85486097d7f49d0c33d06b |
---|---|
record_format |
Article |
spelling |
doaj-20870c2a9c85486097d7f49d0c33d06b2021-03-04T10:22:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011412e022550110.1371/journal.pone.0225501Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial.Mariangela Ivette Guanipa OrtizCristiane de Melo AlencarBrennda Lucy Freitas De PaulaEliane Bemerguy AlvesJesuína Lamartine Nogueira AraújoCecy Martins Silva<h4>Objective</h4>This randomized controlled clinical trial aimed to evaluate the effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) in the treatment of dentin hypersensitivity (DH), and the impact of this on the health-related quality of life (HRQL).<h4>Methods</h4>Eighty teeth with DH were randomized into four groups and received three treatment sessions: PLACEBO = placebo + LASER application mimicking; CPP-ACPF = CPP-ACPF + LASER application mimicking; PBM = placebo + LASER active application; CPP-ACPF+PBM = CPP-ACPF + LASER active application. Tactile (exploratory probe) and evaporative (triple syringe) stimuli were used to measure DH and were recorded with the aid of a visual analogue scale (VAS) after the 1st, 2nd and 3rd treatment sessions and one-month follow-up. The HRQL was recorded in the DH experience questionnaire (DHEQ).<h4>Results</h4>The intragroup comparison showed a significant reduction in DH (p < 0.05) with both stimuli after one-month follow-up. The intergroup comparison with the evaporative stimulus showed that CPP-ACPF+PBM significantly reduced DH when compared to the rest of treatments, after one-month follow-up. CPP-ACPF+PBM group statistically differed from the other treatment groups in the DHEQ evaluation after one-month follow-up.<h4>Conclusion</h4>After one-month follow-up, the association of CPP-ACPF with PBM was effective in the reduction of DH and promoted a positive impact on the HRQL of the participants of this study.https://doi.org/10.1371/journal.pone.0225501 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mariangela Ivette Guanipa Ortiz Cristiane de Melo Alencar Brennda Lucy Freitas De Paula Eliane Bemerguy Alves Jesuína Lamartine Nogueira Araújo Cecy Martins Silva |
spellingShingle |
Mariangela Ivette Guanipa Ortiz Cristiane de Melo Alencar Brennda Lucy Freitas De Paula Eliane Bemerguy Alves Jesuína Lamartine Nogueira Araújo Cecy Martins Silva Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial. PLoS ONE |
author_facet |
Mariangela Ivette Guanipa Ortiz Cristiane de Melo Alencar Brennda Lucy Freitas De Paula Eliane Bemerguy Alves Jesuína Lamartine Nogueira Araújo Cecy Martins Silva |
author_sort |
Mariangela Ivette Guanipa Ortiz |
title |
Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial. |
title_short |
Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial. |
title_full |
Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial. |
title_fullStr |
Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial. |
title_full_unstemmed |
Effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial. |
title_sort |
effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (cpp-acpf) and photobiomodulation (pbm) on dental hypersensitivity: a randomized controlled clinical trial. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
<h4>Objective</h4>This randomized controlled clinical trial aimed to evaluate the effect of the casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF) and photobiomodulation (PBM) in the treatment of dentin hypersensitivity (DH), and the impact of this on the health-related quality of life (HRQL).<h4>Methods</h4>Eighty teeth with DH were randomized into four groups and received three treatment sessions: PLACEBO = placebo + LASER application mimicking; CPP-ACPF = CPP-ACPF + LASER application mimicking; PBM = placebo + LASER active application; CPP-ACPF+PBM = CPP-ACPF + LASER active application. Tactile (exploratory probe) and evaporative (triple syringe) stimuli were used to measure DH and were recorded with the aid of a visual analogue scale (VAS) after the 1st, 2nd and 3rd treatment sessions and one-month follow-up. The HRQL was recorded in the DH experience questionnaire (DHEQ).<h4>Results</h4>The intragroup comparison showed a significant reduction in DH (p < 0.05) with both stimuli after one-month follow-up. The intergroup comparison with the evaporative stimulus showed that CPP-ACPF+PBM significantly reduced DH when compared to the rest of treatments, after one-month follow-up. CPP-ACPF+PBM group statistically differed from the other treatment groups in the DHEQ evaluation after one-month follow-up.<h4>Conclusion</h4>After one-month follow-up, the association of CPP-ACPF with PBM was effective in the reduction of DH and promoted a positive impact on the HRQL of the participants of this study. |
url |
https://doi.org/10.1371/journal.pone.0225501 |
work_keys_str_mv |
AT mariangelaivetteguanipaortiz effectofthecaseinphosphopeptideamorphouscalciumphosphatefluoridecppacpfandphotobiomodulationpbmondentalhypersensitivityarandomizedcontrolledclinicaltrial AT cristianedemeloalencar effectofthecaseinphosphopeptideamorphouscalciumphosphatefluoridecppacpfandphotobiomodulationpbmondentalhypersensitivityarandomizedcontrolledclinicaltrial AT brenndalucyfreitasdepaula effectofthecaseinphosphopeptideamorphouscalciumphosphatefluoridecppacpfandphotobiomodulationpbmondentalhypersensitivityarandomizedcontrolledclinicaltrial AT elianebemerguyalves effectofthecaseinphosphopeptideamorphouscalciumphosphatefluoridecppacpfandphotobiomodulationpbmondentalhypersensitivityarandomizedcontrolledclinicaltrial AT jesuinalamartinenogueiraaraujo effectofthecaseinphosphopeptideamorphouscalciumphosphatefluoridecppacpfandphotobiomodulationpbmondentalhypersensitivityarandomizedcontrolledclinicaltrial AT cecymartinssilva effectofthecaseinphosphopeptideamorphouscalciumphosphatefluoridecppacpfandphotobiomodulationpbmondentalhypersensitivityarandomizedcontrolledclinicaltrial |
_version_ |
1714806283092099072 |